Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lysine (K)-specific demethylase 4A | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | acylamino acid releasing enzyme | 0.0341 | 0.0504 | 0.0592 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.5639 | 1 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.5639 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0341 | 0.0504 | 0.0725 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9B | 0.1628 | 0.2811 | 1 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.5639 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.5639 | 1 | 0.5 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0341 | 0.0504 | 0.0592 |
Echinococcus multilocularis | acylamino acid releasing enzyme | 0.0341 | 0.0504 | 0.0592 |
Loa Loa (eye worm) | hypothetical protein | 0.1107 | 0.1876 | 0.2701 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0732 | 0.1205 | 1 |
Echinococcus granulosus | Dipeptidyl peptidase 9 | 0.1628 | 0.2811 | 0.3961 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S9B | 0.1628 | 0.2811 | 1 |
Schistosoma mansoni | dipeptidyl-peptidase 9 (S09 family) | 0.1628 | 0.2811 | 0.3998 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.5639 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0732 | 0.1205 | 1 |
Brugia malayi | prolyl oligopeptidase family protein | 0.1628 | 0.2811 | 0.3961 |
Loa Loa (eye worm) | hypothetical protein | 0.0341 | 0.0504 | 0.0725 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0073 | 0.0022 | 0.0032 |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.3935 | 0.6946 | 1 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0341 | 0.0504 | 0.065 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0341 | 0.0504 | 0.5 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0341 | 0.0504 | 0.5 |
Trichomonas vaginalis | Clan SC, family S9, acylaminoacyl-peptidase-like serine peptidase | 0.0341 | 0.0504 | 0.5 |
Brugia malayi | prolyl oligopeptidase family protein | 0.3935 | 0.6946 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0522 | 0.0827 | 0.119 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0732 | 0.1205 | 1 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.3935 | 0.6946 | 1 |
Toxoplasma gondii | dipeptidyl peptidase iv (dpp iv) n-terminal region domain-containing protein | 0.1448 | 0.2488 | 1 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.3935 | 0.6946 | 1 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0341 | 0.0504 | 0.0592 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0341 | 0.0504 | 0.5 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0341 | 0.0504 | 0.0725 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.5639 | 1 | 1 |
Echinococcus multilocularis | prolyl endopeptidase | 0.0341 | 0.0504 | 0.0592 |
Trypanosoma brucei | Dipeptidyl-peptidase 8-like, putative | 0.1628 | 0.2811 | 1 |
Brugia malayi | hypothetical protein | 0.1107 | 0.1876 | 0.2596 |
Mycobacterium leprae | PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) | 0.0341 | 0.0504 | 0.5 |
Leishmania major | dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B | 0.1628 | 0.2811 | 1 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0341 | 0.0504 | 0.065 |
Trypanosoma cruzi | dipeptidyl-peptidase 8-like serine peptidase | 0.1628 | 0.2811 | 1 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.5639 | 1 | 1 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0341 | 0.0504 | 0.0592 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.3935 | 0.6946 | 1 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.3935 | 0.6946 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0732 | 0.1205 | 1 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0341 | 0.0504 | 0.065 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0732 | 0.1205 | 1 |
Echinococcus granulosus | prolyl endopeptidase | 0.0341 | 0.0504 | 0.0592 |
Schistosoma mansoni | acylaminoacyl-peptidase (S09 family) | 0.0341 | 0.0504 | 0.065 |
Echinococcus multilocularis | Dipeptidyl peptidase 9 | 0.1628 | 0.2811 | 0.3961 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0341 | 0.0504 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.7783 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.